Cleveland Clinic and the University of Western Ontario have been awarded a $4.9 million grant from Helmsley Charitable Trust to build a consortium to develop clinical trial outcome tools for patients with Crohn’s disease and permanent ileostomy.
CDR-404 by CDR-Life for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
CDR-404 is under clinical development by CDR-Life and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).